Literature DB >> 18493768

Encephalic large arteries narrowness and peripheral neuropathy in a patient with adult-onset Still's disease.

Hong Zhao1, Yun Yuan, Yue Li, Chong-Wen Si, Geng-Shan Tian, Gui-Qiang Wang, Xue-Dong Yang.   

Abstract

Adult-onset Still's disease (AOSD) is a rare, systemic inflammatory disorder, characterized by spiking high fever, fever-associated evanescent rash, arthritis, myalgia, serositis and hepatosplenomegaly. White blood cell count, neutrophilic cell count, and serum ferritin level are markedly elevated in the active stage of the disease. Neurological complications of AOSD commonly were cranial nerve palsies, seizures, aseptic meningoencephalitis, peripheral neuropathy and Miller-Fisher syndrome. We report a previously healthy 60-year-old Chinese man who fulfilled the criteria for AOSD and had a combination of focal and peripheral neurological symptoms. Magnetic resonance angiography (MRA) and transcranial Doppler ultrasonography (TCD) showed narrowness of cerebral blood vessel. Peripheral neuropathy was confirmed by electromyography and sural nerve biopsy. His generalized neuropathy and other symptoms were rapidly improved by receiving glucocorticoid therapy. We do a literature review about neurological manifestations observed in AOSD patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18493768     DOI: 10.1007/s00296-008-0599-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  12 in total

1.  Aseptic meningitis and cranial nerve palsy revealing adult-onset Still's disease.

Authors:  I Marie; H Levesque; N Perraudin; N Cailleux; F Lecomte; H Courtois
Journal:  Clin Infect Dis       Date:  1999-07       Impact factor: 9.079

2.  Proposal for a new set of classification criteria for adult-onset still disease.

Authors:  Bruno Fautrel; Emmanuel Zing; Jean-Louis Golmard; Giselle Le Moel; Anne Bissery; Christophe Rioux; Sylvie Rozenberg; Jean-Charles Piette; Pierre Bourgeois
Journal:  Medicine (Baltimore)       Date:  2002-05       Impact factor: 1.889

3.  Adult Still's disease: a multicenter survey of Japanese patients.

Authors:  A Ohta; M Yamaguchi; T Tsunematsu; R Kasukawa; H Mizushima; H Kashiwagi; S Kashiwazaki; K Tanimoto; Y Matsumoto; M Akizuki
Journal:  J Rheumatol       Date:  1990-08       Impact factor: 4.666

4.  Preliminary criteria for classification of adult Still's disease.

Authors:  M Yamaguchi; A Ohta; T Tsunematsu; R Kasukawa; Y Mizushima; H Kashiwagi; S Kashiwazaki; K Tanimoto; Y Matsumoto; T Ota
Journal:  J Rheumatol       Date:  1992-03       Impact factor: 4.666

5.  Nasal septal perforation: a novel clinical manifestation of systemic juvenile idiopathic arthritis/adult onset Still's disease.

Authors:  Tadej Avcin; Earl D Silverman; Vito Forte; Rayfel Schneider
Journal:  J Rheumatol       Date:  2005-12       Impact factor: 4.666

Review 6.  Miller Fisher syndrome in adult onset Still's disease: case report and review of the literature of other neurological manifestations.

Authors:  S S Desai; E Allen; A Deodhar
Journal:  Rheumatology (Oxford)       Date:  2002-02       Impact factor: 7.580

7.  Adult-onset Still disease as the cause of fever of unknown origin.

Authors:  José C Crispín; Deborah Martínez-Baños; Jorge Alcocer-Varela
Journal:  Medicine (Baltimore)       Date:  2005-11       Impact factor: 1.889

8.  Neutrophilic pleocytosis in cerebrospinal fluid: adult-onset Still's disease.

Authors:  Fehmi Tabak; Melike Tanverdi; Resat Ozaras; Ali Mert; Zeynep Tartan; Recep Ozturk; Yildirim Aktuglu
Journal:  Intern Med       Date:  2003-10       Impact factor: 1.271

9.  Sensorineural hearing loss in adult onset Still's disease.

Authors:  H M Markusse; B Stolk; A G van der Mey; J M de Jonge-Bok; K J Heering
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

10.  Disseminated cerebral thrombotic microangiopathy in a patient with adult's still disease.

Authors:  Renan B Domingues; Ana Maria Casati da Gama; Eliana B Caser; Carlos Musso; Maria Carmen S Santos
Journal:  Arq Neuropsiquiatr       Date:  2003-06-09       Impact factor: 1.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.